Evidence map›Paper›PMID 24958161›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2014

Linalool and linalool complexed in β-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia.

Simone S Nascimento, Enilton A Camargo, Josimari M DeSantana, Adriano A S Araújo, Paula P Menezes, Waldecy Lucca-Júnior, Ricardo L C Albuquerque-Júnior, Leonardo R Bonjardim, Lucindo J Quintans-Júnior

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Analgesic Potential of Terpenes Derived fromPharmacological reviews · 2021
    Review
  11. Review
  12. Increased Accuracy to c-Fos-Positive Neuron Counting.BioMed research international · 2021
    Article
  13. Cyclodextrin⁻Drug Inclusion Complexes: In Vivo and In Vitro Approaches.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Analgesic-Like Activity of Essential Oil Constituents: An Update.International journal of molecular sciences · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Simone S NascimentoDepartment of Physiology, Federal University of Sergipe (DFS/UFS), Av. Marechal Rondom, s/n, São Cristóvão, SE, Brazil.
Enilton A Camargo
Josimari M DeSantana
Adriano A S Araújo
Paula P Menezes
Waldecy Lucca-Júnior
Ricardo L C Albuquerque-Júnior
Leonardo R Bonjardim
Lucindo J Quintans-Júnior
Universidade Federal de Sergipe · BRUniversidade de São Paulo · BRUniversidade Tiradentes · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The analgesic activity of (-)-linalool (LIN), a monoterpene present in essential oils of Lamiaceae species, has been previously demonstrated in rodents. However, its possible use in the treatment of fibromyalgia (FM) was never demonstrated. Additionally, as a short half-life is a limitation for the LIN medicinal application, the employment of drug delivery systems has been used to improve pharmaceutical properties of this compound. We investigated the anti-nociceptive effect of LIN, isolated or in β-cyclodextrin complex (LIN-CD), in an animal model of chronic non-inflammatory muscle pain (a FM animal model), as well as its effect on the central nervous system (CNS). Male Swiss mice were subjected to two injections of acidic saline (pH 4; 20 μL/gastrocnemius) and were treated on alternate days, with LIN-CD (25 mg/kg, p.o.), LIN (25 mg/kg, p.o.), tramadol (TRM 4 mg/kg, i.p.), or vehicle (neutral saline). After 60 min, they were screened for mechanical hyperalgesia (von Frey), motor coordination (rotarod), and muscle strength (grip strength meter) for 27 days. The CNS areas involved in the anti-hyperalgesic activity were evaluated by immunofluorescence. LIN or LIN-CD produced a significant reduction (p < 0.001) of mechanical hyperalgesia on chronic non-inflammatory muscle pain model, which remained for 24 h only in LIN-CD, and these compounds significantly (p < 0.05) activated neurons of the locus coeruleus, nucleus raphe magnus, and periaqueductal gray areas. So, our results suggest that LIN-CD improved analgesic profile of LIN, with a probable involvement of descending pain pathways and the anti-nociceptive effect of linalool in an animal model of chronic non-inflammatory muscle pain. So far, only the investigations in animal models of inflammatory pain and supraspinatus were published.

Indexed as

Disease Models, AnimalAcyclic MonoterpenesAnimalsbeta-CyclodextrinsDrug Therapy, CombinationFibromyalgiaGene Expression RegulationHyperalgesiaMaleMiceMonoterpenesPain MeasurementProto-Oncogene Proteins c-fosAcyclic Monoterpenesbeta-CyclodextrinsbetadexlinaloolMonoterpenesProto-Oncogene Proteins c-fos

Identifiers

PMID24958161
OpenAlexW2049234525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.